Avoiding Harm From Hyperbilirubinemia Screening-Reply
JAMA Pediatr
.
2019 Dec 1;173(12):1209-1210.
doi: 10.1001/jamapediatrics.2019.3762.
Authors
Scott D Grosse
1
,
Lisa A Prosser
2
3
,
Jeffrey R Botkin
4
Affiliations
1
National Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, Georgia.
2
Department of Health Management and Policy, University of Michigan, Ann Arbor.
3
Susan B. Meister Child Health Evaluation and Research Center, Department of Pediatrics, University of Michigan, Ann Arbor.
4
Department of Pediatrics, The University of Utah, Salt Lake City.
PMID:
31589244
PMCID:
PMC7203610
DOI:
10.1001/jamapediatrics.2019.3762
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Hyperbilirubinemia, Neonatal* / diagnosis
Infant, Newborn
Mass Screening
Grants and funding
CC999999/ImCDC/Intramural CDC HHS/United States